ArticleOncotarget2016

Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN-glioblastoma in vivo.

Wen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.